Newer Treatment Approaches for Type 2 Diabetes Mellitus
dc.contributor.advisor | Pórszász, Róbert | |
dc.contributor.advisordept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
dc.contributor.author | Mariadasan, Lydia | |
dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
dc.contributor.opponent | Drimba, László | |
dc.contributor.opponent | Szentmiklósi, József András | |
dc.contributor.opponentdept | Debreceni Egyetem | hu_HU |
dc.contributor.opponentdept | Kenézy Kórház Aneszteziológiai és Intenziv Therápiás Intézet | hu_HU |
dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
dc.date.accessioned | 2015-11-16T09:19:02Z | |
dc.date.available | 2015-11-16T09:19:02Z | |
dc.date.created | 2015-02 | |
dc.description.abstract | Type 2 diabetes mellitus is a chronic metabolic disorder that results from defects in both insulin secretion and insulin action. Type 2 diabetes can initially be treated with oral agent monotherapy, but due to the progressive nature of this disorder, patients eventually require the addition of other oral agents, often as a prelude to insulin therapy. Several new approaches are developed to improve glycemic control with minimum side effects. | hu_HU |
dc.description.course | általános orvos | hu_HU |
dc.description.courselang | angol | hu_HU |
dc.description.degree | egységes, osztatlan | hu_HU |
dc.format.extent | 40 | hu_HU |
dc.identifier.uri | http://hdl.handle.net/2437/218340 | |
dc.language.iso | en | hu_HU |
dc.subject | diabetes mellitus type 2 | hu_HU |
dc.subject | anti-diabetic drugs | |
dc.subject | sulfonylureas | |
dc.subject | rapid-acting insulin secretagogues | |
dc.subject | metformin | |
dc.subject | thiazolidinediones | |
dc.subject | α-glucosidase inhibitors | |
dc.subject | incretin analogue based therapies 19 glucagon-like-peptide-1 receptor agonist | |
dc.subject | dipeptidyl peptidase-4 inhibitors | |
dc.subject | sodium-glucose co-transporter type 2 inhibitors | |
dc.subject | pramlintide | |
dc.subject.dspace | UNL Thread List::Medicine | hu_HU |
dc.title | Newer Treatment Approaches for Type 2 Diabetes Mellitus | hu_HU |